Hematologist Discovers, Names The 'Toms River' Blood Mutation In N.J. Family
6/17/2011
A newborn described as a "happy blue baby" because of her bluish skin color but healthy appearance made a small mark in medical history when one of her physicians discovered something new in her genes - the hemoglobin Toms River mutation...
New Australian Drug Shows Positive Response In Patients With Multiple Myeloma Blood Cancer
6/17/2011
Australian monoclonal antibody company, Immune System Therapeutics Limited (IST), today announced it would double patient recruitment in its Phase II trial for a breakthrough antibody treatment for terminal blood cancer...
Oncologist Reviews The FDA-Avastin Decision
6/17/2011
Controversy over the F.D.A.'s proposal to withdraw approval of Avastin (bevacizumab) for breast cancer treatment will reignite June 28-29 with a new round of hearings. One oncologist who will be monitoring the hearings is Dr. Frederick C. Tucker Jr. of Fredericksburg Oncology in Virginia, whose recent New York Times op ed defended the F.D.A.'s position on scientific grounds. Dr...
Is Eating Soy Safe For Breast Cancer Patients?
6/17/2011
There has been widespread concern about whether it is safe for women with breast cancer to eat soy. An excellent source of fiber, vitamin B6 and protein, soy is usually associated with a health-conscious diet, but research concerning its safety has been mixed...
A study from Australia is the first to show reduction of high-grade cervical abnormalities (HGAs-the precursors to cervical cancer) in a population of women following introduction of human papillomavirus (HPV) vaccination programmes. However, the authors add that more work is needed to link this lower incidence definitively to vaccination status...
Deprivation Leads To Over 2,600 Cancer Deaths A Year
6/16/2011
MORE than 2,600 deaths in England from some of the most common types of cancer could be avoided each year if all cancer patients had the same chance of survival as the most affluent section of society, a new piece of research suggests...
Barrett's Esophagus Carries Lower Risk Of Malignancy Than Previously Estimated
6/16/2011
Patients with Barrett's esophagus may have a lower risk of esophageal cancer than previously reported, according to a large, long-term study published online June 16 in the Journal of the National Cancer Institute...
Glioblastomas, the most common and most aggressive brain tumors, apparently arise from neural stem cells (NSCs) in the brain. Researchers are now beginning to understand the mechanisms of how NSCs, which are present in small quantities in the adult brain and which are responsible for the production of new neurons, give rise to tumor stem cells...
The US Food and Drug Administration (FDA) is often criticized as inefficient compared to its European counterpart, the European Medicines Agency (EMA), particularly in the field of oncology...
Oncologist Reviews The FDA-Avastin Decision
6/16/2011
Controversy over the F.D.A.'s proposal to withdraw approval of Avastin (bevacizumab) for breast cancer treatment will reignite June 28-29 with a new round of hearings. One oncologist who will be monitoring the hearings is Dr. Frederick C. Tucker Jr. of Fredericksburg Oncology in Virginia, whose recent New York Times op ed defended the F.D.A.'s position on scientific grounds. Dr...